520 related articles for article (PubMed ID: 25257148)
1. Analysis of potentially predictive factors of efficacy of adjunct extended-release quetiapine fumarate in patients with major depressive disorder.
Bauer M; Thase ME; Liu S; Earley W; Eriksson H
J Psychopharmacol; 2015 May; 29(5):565-74. PubMed ID: 25257148
[TBL] [Abstract][Full Text] [Related]
2. Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study.
El-Khalili N; Joyce M; Atkinson S; Buynak RJ; Datto C; Lindgren P; Eriksson H
Int J Neuropsychopharmacol; 2010 Aug; 13(7):917-32. PubMed ID: 20175941
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of extended release quetiapine fumarate monotherapy in patients with major depressive disorder: a pooled analysis of two 6-week, double-blind, placebo-controlled studies.
Weisler RH; Montgomery SA; Earley WR; Szamosi J; Lazarus A
Int Clin Psychopharmacol; 2012 Jan; 27(1):27-39. PubMed ID: 22027845
[TBL] [Abstract][Full Text] [Related]
4. Randomized, double-blind study of the efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in elderly patients with major depressive disorder.
Katila H; Mezhebovsky I; Mulroy A; Berggren L; Eriksson H; Earley W; Datto C
Am J Geriatr Psychiatry; 2013 Aug; 21(8):769-84. PubMed ID: 23567397
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of adjunct extended-release quetiapine fumarate on sleep disturbance and quality in patients with major depressive disorder and an inadequate response to on-going antidepressant therapy.
Bauer M; McIntyre RS; Szamosi J; Eriksson H
Int J Neuropsychopharmacol; 2013 Sep; 16(8):1755-65. PubMed ID: 23672772
[TBL] [Abstract][Full Text] [Related]
6. Extended-release quetiapine fumarate (quetiapine XR) monotherapy and quetiapine XR or lithium as add-on to antidepressants in patients with treatment-resistant major depressive disorder.
Bauer M; Dell'osso L; Kasper S; Pitchot W; Dencker Vansvik E; Köhler J; Jørgensen L; Montgomery SA
J Affect Disord; 2013 Oct; 151(1):209-19. PubMed ID: 23810357
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the effects of extended release quetiapine fumarate monotherapy on sleep disturbance in patients with major depressive disorder: a pooled analysis of four randomized acute studies.
Trivedi MH; Bandelow B; Demyttenaere K; Papakostas GI; Szamosi J; Earley W; Eriksson H
Int J Neuropsychopharmacol; 2013 Sep; 16(8):1733-44. PubMed ID: 23673347
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial.
Liebowitz M; Lam RW; Lepola U; Datto C; Sweitzer D; Eriksson H
Depress Anxiety; 2010 Oct; 27(10):964-76. PubMed ID: 20734365
[TBL] [Abstract][Full Text] [Related]
9. Extended-release quetiapine as adjunct to an antidepressant in patients with major depressive disorder: results of a randomized, placebo-controlled, double-blind study.
Bauer M; Pretorius HW; Constant EL; Earley WR; Szamosi J; Brecher M
J Clin Psychiatry; 2009 Apr; 70(4):540-9. PubMed ID: 19358791
[TBL] [Abstract][Full Text] [Related]
10. Extended release quetiapine fumarate as adjunct to antidepressant therapy in patients with major depressive disorder: pooled analyses of data in patients with anxious depression versus low levels of anxiety at baseline.
Bandelow B; Bauer M; Vieta E; El-Khalili N; Gustafsson U; Earley WR; Eriksson H
World J Biol Psychiatry; 2014 Feb; 15(2):155-66. PubMed ID: 24506289
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of extended release quetiapine fumarate monotherapy in elderly patients with major depressive disorder: secondary analyses in subgroups of patients according to baseline anxiety, sleep disturbance, and pain levels.
Montgomery SA; Altamura AC; Katila H; Datto C; Szamosi J; Eriksson H
Int Clin Psychopharmacol; 2014 Mar; 29(2):93-105. PubMed ID: 24162081
[TBL] [Abstract][Full Text] [Related]
12. Pooled analysis of adjunct extended-release quetiapine fumarate in patients with major depressive disorder according to ongoing SSRI or SNRI treatment.
Bauer M; Demyttenaere K; El-Khalili N; Thase ME; Papakostas GI; Szamosi J; Earley WR; Eriksson H
Int Clin Psychopharmacol; 2014 Jan; 29(1):16-25. PubMed ID: 24108148
[TBL] [Abstract][Full Text] [Related]
13. Extended release quetiapine fumarate in patients with major depressive disorder: suicidality data from acute and maintenance studies.
Weisler R; Montgomery SA; Earley WR; Szamosi J; Eriksson H
J Clin Psychiatry; 2014 May; 75(5):520-7. PubMed ID: 24816198
[TBL] [Abstract][Full Text] [Related]
14. Pooled analysis of sustained response rates for extended release quetiapine fumarate as monotherapy or adjunct to antidepressant therapy in patients with major depressive disorder.
Vieta E; Bauer M; Montgomery S; McIntyre RS; Szamosi J; Earley WR; Eriksson H
J Affect Disord; 2013 Sep; 150(2):639-43. PubMed ID: 23497790
[TBL] [Abstract][Full Text] [Related]
15. Extended release quetiapine fumarate in major depressive disorder: analysis in patients with anxious depression.
Thase ME; Demyttenaere K; Earley WR; Gustafsson U; Udd M; Eriksson H
Depress Anxiety; 2012 Jul; 29(7):574-86. PubMed ID: 22753280
[TBL] [Abstract][Full Text] [Related]
16. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.
Cutler AJ; Datto C; Nordenhem A; Minkwitz M; Acevedo L; Darko D
Clin Ther; 2011 Nov; 33(11):1643-58. PubMed ID: 22054797
[TBL] [Abstract][Full Text] [Related]
17. Extended release quetiapine fumarate monotherapy in major depressive disorder: a placebo- and duloxetine-controlled study.
Cutler AJ; Montgomery SA; Feifel D; Lazarus A; Aström M; Brecher M
J Clin Psychiatry; 2009 Apr; 70(4):526-39. PubMed ID: 19358790
[TBL] [Abstract][Full Text] [Related]
18. Extended release quetiapine fumarate monotherapy for major depressive disorder: results of a double-blind, randomized, placebo-controlled study.
Weisler R; Joyce M; McGill L; Lazarus A; Szamosi J; Eriksson H;
CNS Spectr; 2009 Jun; 14(6):299-313. PubMed ID: 19668121
[TBL] [Abstract][Full Text] [Related]
19. Long-term mood/antidepressant effects of quetiapine extended-release formulation: an open-label, non-controlled extension study in Japanese patients with bipolar depression.
Kanba S; Murasaki M; Koyama T; Takeuchi M; Shimizu Y; Arita E; Kuroishi K; Takeuchi M; Kamei S
BMC Psychiatry; 2019 Jun; 19(1):198. PubMed ID: 31242884
[TBL] [Abstract][Full Text] [Related]
20. Quetiapine fumarate extended-release for the treatment of major depression with comorbid fibromyalgia syndrome: a double-blind, randomized, placebo-controlled study.
McIntyre A; Paisley D; Kouassi E; Gendron A
Arthritis Rheumatol; 2014 Feb; 66(2):451-61. PubMed ID: 24504819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
